Literature DB >> 11246204

NMR conformational analysis of cis and trans proline isomers in the neutrophil chemoattractant, N-acetyl-proline-glycine-proline.

Y C Lee1, P L Jackson, M J Jablonsky, D D Muccio, R R Pfister, J L Haddox, C I Sommers, G M Anantharamaiah, M Chaddha.   

Abstract

Alkaline hydrolysis of corneal proteins in the alkali-injured eye releases N-acetyl-proline-glycine-proline (Ac-Pro-Gly-Pro-OH) among other peptides. It has been shown that this tripeptide is a neutrophil chemoattractant. Existing data suggest that the release of this peptide is the catalytic event for early neutrophil invasion of the cornea leading to corneal ulcers. In order to design inhibitors of this tripeptide chemoattractant that would block neutrophil invasion and diminish corneal ulcers, we studied the solution properties of this tripeptide by NMR spectroscopy and compared this peptide to Ac-Pro-Gly-OH (a weaker chemoattractant), and to Ac-Pro-OH (inactive). The NMR data were consistent with Ac-Pro-Gly-Pro-OH existing in solution as a mixture of four isomers with different cis and trans conformations about the two X-proline amide bonds. The isomer with two trans conformations (trans-trans) was the most dominant (41%) in aqueous solution. This was followed by the isomers with mixed cis and trans conformations (trans-cis, 26% and cis-trans, 20%). The isomer with two cis conformations (cis-cis) was the least favored (13%). The populations of these isomers were investigated in DMSO and they were similar to those reported in aqueous solutions except that the ordering of the trans-cis and cis-trans isomers were reversed. NMR NH temperature coefficients and nuclear Overhauser effect (NOE) measurements as well as CD spectroscopy were used to demonstrate that the four isomers exist primarily in an extended conformation with little hydrogen bonding. The available (NOE) information was used with molecular dynamics calculations to construct a dominant solution conformation for each isomer of the tripeptide. This information will serve as a model for the design of peptide and nonpeptide inhibitors of the chemoattractant. Copyright 2001 John Wiley & Sons, Inc. Biopolymers 58: 548-561, 2001

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11246204     DOI: 10.1002/1097-0282(200105)58:6<548::AID-BIP1030>3.0.CO;2-B

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  6 in total

Review 1.  MMP generated matrikines.

Authors:  J Michael Wells; Amit Gaggar; J Edwin Blalock
Journal:  Matrix Biol       Date:  2015-01-28       Impact factor: 11.583

2.  A CXCL8 receptor antagonist based on the structure of N-acetyl-proline-glycine-proline.

Authors:  Patricia L Jackson; Brett D Noerager; Michael J Jablonsky; Matthew T Hardison; Bryan D Cox; James C Patterson; Boopathy Dhanapal; J Edwin Blalock; Donald D Muccio
Journal:  Eur J Pharmacol       Date:  2011-03-31       Impact factor: 4.432

3.  Leveraging Fungal and Human Calcineurin-Inhibitor Structures, Biophysical Data, and Dynamics To Design Selective and Nonimmunosuppressive FK506 Analogs.

Authors:  Sophie M-C Gobeil; Benjamin G Bobay; Praveen R Juvvadi; D Christopher Cole; Joseph Heitman; William J Steinbach; Ronald A Venters; Leonard D Spicer
Journal:  mBio       Date:  2021-11-23       Impact factor: 7.867

4.  Photochemical anti-syn isomerization around the -N-N[double bond, length as m-dash] bond in heterocyclic imines.

Authors:  Michal Hricovíni; James Asher; Miloš Hricovíni
Journal:  RSC Adv       Date:  2020-02-04       Impact factor: 4.036

5.  Interplay between Structure and Charge as a Key to Allosteric Modulation of Human 20S Proteasome by the Basic Fragment of HIV-1 Tat Protein.

Authors:  Przemysław Karpowicz; Paweł A Osmulski; Julia Witkowska; Emilia Sikorska; Małgorzata Giżyńska; Agnieszka Belczyk-Ciesielska; Maria E Gaczynska; Elżbieta Jankowska
Journal:  PLoS One       Date:  2015-11-17       Impact factor: 3.240

6.  Investigations of the Copper Peptide Hepcidin-25 by LC-MS/MS and NMR.

Authors:  Ioana M Abbas; Marija Vranic; Holger Hoffmann; Ahmed H El-Khatib; María Montes-Bayón; Heiko M Möller; Michael G Weller
Journal:  Int J Mol Sci       Date:  2018-08-02       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.